nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—AGTR1—nephron—IgA glomerulonephritis	0.278	0.39	CbGeAlD
Eprosartan—CYP2C9—urine—IgA glomerulonephritis	0.107	0.151	CbGeAlD
Eprosartan—AGTR1—nephron tubule—IgA glomerulonephritis	0.06	0.0841	CbGeAlD
Eprosartan—AGTR1—kidney—IgA glomerulonephritis	0.0528	0.0739	CbGeAlD
Eprosartan—AGTR1—cortex of kidney—IgA glomerulonephritis	0.0514	0.072	CbGeAlD
Eprosartan—AGTR1—lymphoid tissue—IgA glomerulonephritis	0.0453	0.0635	CbGeAlD
Eprosartan—ABCC2—nephron tubule—IgA glomerulonephritis	0.0434	0.0608	CbGeAlD
Eprosartan—ABCC2—kidney—IgA glomerulonephritis	0.0381	0.0534	CbGeAlD
Eprosartan—ABCC2—cortex of kidney—IgA glomerulonephritis	0.0372	0.052	CbGeAlD
Eprosartan—Losartan—ACE—IgA glomerulonephritis	0.0113	0.709	CrCbGaD
Eprosartan—Losartan—ALB—IgA glomerulonephritis	0.00461	0.291	CrCbGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NMU—IgA glomerulonephritis	0.00279	0.0103	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—GPR65—IgA glomerulonephritis	0.00278	0.0103	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—FPR3—IgA glomerulonephritis	0.00251	0.0093	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR1—IgA glomerulonephritis	0.00251	0.00929	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—IgA glomerulonephritis	0.00249	0.0092	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DQB1—IgA glomerulonephritis	0.00246	0.00911	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PSAP—IgA glomerulonephritis	0.00235	0.0087	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—C5AR1—IgA glomerulonephritis	0.00233	0.00863	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD40LG—IgA glomerulonephritis	0.00233	0.0086	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADORA3—IgA glomerulonephritis	0.00222	0.00823	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCR5—IgA glomerulonephritis	0.00222	0.0082	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR65—IgA glomerulonephritis	0.00215	0.00795	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NMU—IgA glomerulonephritis	0.00207	0.00764	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—C3—IgA glomerulonephritis	0.00206	0.0076	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—GNG12—IgA glomerulonephritis	0.00204	0.00755	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR1—IgA glomerulonephritis	0.00196	0.00727	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—ALOX5AP—IgA glomerulonephritis	0.00195	0.00722	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—FPR3—IgA glomerulonephritis	0.00191	0.00708	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADORA3—IgA glomerulonephritis	0.00191	0.00705	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DRB1—IgA glomerulonephritis	0.00187	0.00693	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GPR65—IgA glomerulonephritis	0.00184	0.00681	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG12—IgA glomerulonephritis	0.00182	0.00675	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—PSAP—IgA glomerulonephritis	0.00179	0.00663	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD80—IgA glomerulonephritis	0.00173	0.0064	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR1—IgA glomerulonephritis	0.00168	0.00623	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR2—IgA glomerulonephritis	0.00162	0.00598	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—NMU—IgA glomerulonephritis	0.00157	0.00582	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—IgA glomerulonephritis	0.00157	0.00579	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C5AR1—IgA glomerulonephritis	0.00157	0.00579	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—RAB11FIP2—IgA glomerulonephritis	0.00156	0.00576	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—ADORA3—IgA glomerulonephritis	0.00145	0.00537	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—GPR65—IgA glomerulonephritis	0.0014	0.00519	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC20A1—IgA glomerulonephritis	0.00139	0.00513	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IFNG—IgA glomerulonephritis	0.00137	0.00506	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK1—IgA glomerulonephritis	0.00134	0.00496	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—MAT2A—IgA glomerulonephritis	0.00133	0.00493	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CHST2—IgA glomerulonephritis	0.00132	0.00487	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR1—IgA glomerulonephritis	0.00128	0.00474	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR2—IgA glomerulonephritis	0.00127	0.00468	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—C5AR1—IgA glomerulonephritis	0.00119	0.00441	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—IgA glomerulonephritis	0.00116	0.0043	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GGCT—IgA glomerulonephritis	0.00116	0.00428	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ARHGAP11A—IgA glomerulonephritis	0.00115	0.00425	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ARHGAP22—IgA glomerulonephritis	0.00115	0.00425	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—IgA glomerulonephritis	0.00108	0.00401	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—FPR3—IgA glomerulonephritis	0.00108	0.004	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—MTRR—IgA glomerulonephritis	0.00107	0.00398	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC39A8—IgA glomerulonephritis	0.00105	0.00389	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ATP6V1B2—IgA glomerulonephritis	0.00105	0.00389	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC9A6—IgA glomerulonephritis	0.00105	0.00389	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ECT2—IgA glomerulonephritis	0.00105	0.00387	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR5—IgA glomerulonephritis	0.00104	0.00386	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—GNG12—IgA glomerulonephritis	0.00103	0.00381	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—C3—IgA glomerulonephritis	0.00102	0.00377	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A20—IgA glomerulonephritis	0.001	0.00371	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC7A5—IgA glomerulonephritis	0.001	0.00371	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—FPR3—IgA glomerulonephritis	0.000983	0.00364	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—AGT—IgA glomerulonephritis	0.00098	0.00363	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—AGT—IgA glomerulonephritis	0.000968	0.00358	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC30A5—IgA glomerulonephritis	0.000961	0.00356	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC38A2—IgA glomerulonephritis	0.000961	0.00356	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—HMOX1—IgA glomerulonephritis	0.000953	0.00353	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ECT2—IgA glomerulonephritis	0.000949	0.00351	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—IgA glomerulonephritis	0.000948	0.00351	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PSAP—IgA glomerulonephritis	0.000919	0.0034	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—PTHLH—IgA glomerulonephritis	0.000903	0.00334	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NMU—IgA glomerulonephritis	0.000889	0.00329	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—IgA glomerulonephritis	0.000877	0.00324	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RGS4—IgA glomerulonephritis	0.000836	0.00309	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR2—IgA glomerulonephritis	0.000826	0.00306	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADORA3—IgA glomerulonephritis	0.00082	0.00303	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—IgA glomerulonephritis	0.000816	0.00302	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NMU—IgA glomerulonephritis	0.000807	0.00299	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL2—IgA glomerulonephritis	0.000797	0.00295	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—METAP2—IgA glomerulonephritis	0.000796	0.00294	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GPR65—IgA glomerulonephritis	0.000792	0.00293	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RGS4—IgA glomerulonephritis	0.000759	0.00281	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADORA3—IgA glomerulonephritis	0.000745	0.00276	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR1—IgA glomerulonephritis	0.000724	0.00268	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GPR65—IgA glomerulonephritis	0.000719	0.00266	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—IgA glomerulonephritis	0.000699	0.00259	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—IgA glomerulonephritis	0.000683	0.00253	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C5AR1—IgA glomerulonephritis	0.000673	0.00249	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ATP6V1B2—IgA glomerulonephritis	0.000659	0.00244	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TMED2—IgA glomerulonephritis	0.000659	0.00244	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR1—IgA glomerulonephritis	0.000658	0.00243	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—IgA glomerulonephritis	0.000649	0.0024	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ATP2B1—IgA glomerulonephritis	0.000646	0.00239	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TBL1XR1—IgA glomerulonephritis	0.000619	0.00229	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C5AR1—IgA glomerulonephritis	0.000612	0.00226	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ETNK1—IgA glomerulonephritis	0.000586	0.00217	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SGPP1—IgA glomerulonephritis	0.000586	0.00217	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPGAT1—IgA glomerulonephritis	0.000586	0.00217	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GNG12—IgA glomerulonephritis	0.000581	0.00215	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FPR3—IgA glomerulonephritis	0.000581	0.00215	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC1A3—IgA glomerulonephritis	0.000576	0.00213	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ECT2—IgA glomerulonephritis	0.000561	0.00207	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PSAP—IgA glomerulonephritis	0.000543	0.00201	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—IgA glomerulonephritis	0.000535	0.00198	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR5—IgA glomerulonephritis	0.000532	0.00197	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GNG12—IgA glomerulonephritis	0.000528	0.00195	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADAM12—IgA glomerulonephritis	0.000527	0.00195	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—C3—IgA glomerulonephritis	0.00052	0.00192	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—CP—IgA glomerulonephritis	0.000513	0.0019	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ABI1—IgA glomerulonephritis	0.000513	0.0019	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PTHLH—IgA glomerulonephritis	0.00051	0.00189	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CAB39—IgA glomerulonephritis	0.0005	0.00185	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GNG12—IgA glomerulonephritis	0.000497	0.00184	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—AGT—IgA glomerulonephritis	0.000494	0.00183	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL6—IgA glomerulonephritis	0.000485	0.0018	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—DEGS1—IgA glomerulonephritis	0.000485	0.0018	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCNC—IgA glomerulonephritis	0.000477	0.00176	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NMU—IgA glomerulonephritis	0.000477	0.00176	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR2—IgA glomerulonephritis	0.000467	0.00173	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PTHLH—IgA glomerulonephritis	0.000464	0.00171	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—IgA glomerulonephritis	0.000458	0.00169	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RGS4—IgA glomerulonephritis	0.000448	0.00166	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—UGCG—IgA glomerulonephritis	0.000444	0.00164	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—IgA glomerulonephritis	0.000444	0.00164	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADORA3—IgA glomerulonephritis	0.00044	0.00163	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GPR65—IgA glomerulonephritis	0.000425	0.00157	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR2—IgA glomerulonephritis	0.000424	0.00157	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—IgA glomerulonephritis	0.000417	0.00154	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—IgA glomerulonephritis	0.000413	0.00153	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—IgA glomerulonephritis	0.000407	0.00151	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—UBE2D3—IgA glomerulonephritis	0.000405	0.0015	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—PIK3CA—IgA glomerulonephritis	0.000405	0.0015	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PSAP—IgA glomerulonephritis	0.0004	0.00148	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HEXB—IgA glomerulonephritis	0.0004	0.00148	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RACGAP1—IgA glomerulonephritis	0.000399	0.00148	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TBL1XR1—IgA glomerulonephritis	0.000389	0.00144	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR1—IgA glomerulonephritis	0.000389	0.00144	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ITCH—IgA glomerulonephritis	0.000389	0.00144	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—TNFRSF21—IgA glomerulonephritis	0.000388	0.00144	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—IgA glomerulonephritis	0.000378	0.0014	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—VAV3—IgA glomerulonephritis	0.000367	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—IgA glomerulonephritis	0.000362	0.00134	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—IgA glomerulonephritis	0.000362	0.00134	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C5AR1—IgA glomerulonephritis	0.000361	0.00134	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CCNC—IgA glomerulonephritis	0.000351	0.0013	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—YES1—IgA glomerulonephritis	0.000343	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—VAV3—IgA glomerulonephritis	0.000333	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CHEK1—IgA glomerulonephritis	0.000328	0.00121	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CYBB—IgA glomerulonephritis	0.000322	0.00119	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LYPLA1—IgA glomerulonephritis	0.00032	0.00118	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CMPK1—IgA glomerulonephritis	0.00032	0.00118	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GNG12—IgA glomerulonephritis	0.000312	0.00115	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—HMOX1—IgA glomerulonephritis	0.000305	0.00113	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ACSL1—IgA glomerulonephritis	0.000303	0.00112	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—IgA glomerulonephritis	0.000301	0.00111	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NCF2—IgA glomerulonephritis	0.000295	0.00109	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C3—IgA glomerulonephritis	0.000294	0.00109	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RASA1—IgA glomerulonephritis	0.000287	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SEC23A—IgA glomerulonephritis	0.000286	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—TBL1XR1—IgA glomerulonephritis	0.000286	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MINPP1—IgA glomerulonephritis	0.000285	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AZIN1—IgA glomerulonephritis	0.000285	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BCAT1—IgA glomerulonephritis	0.000285	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NNT—IgA glomerulonephritis	0.000285	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—RPE—IgA glomerulonephritis	0.000285	0.00106	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EREG—IgA glomerulonephritis	0.00028	0.00104	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AGT—IgA glomerulonephritis	0.000279	0.00103	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—IgA glomerulonephritis	0.000279	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTHLH—IgA glomerulonephritis	0.000274	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—IgA glomerulonephritis	0.000273	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C3—IgA glomerulonephritis	0.000267	0.000988	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ETNK1—IgA glomerulonephritis	0.000261	0.000965	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADSS—IgA glomerulonephritis	0.000261	0.000965	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPGAT1—IgA glomerulonephritis	0.000261	0.000965	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SGPP1—IgA glomerulonephritis	0.000261	0.000965	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PSME3—IgA glomerulonephritis	0.000259	0.000957	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGT—IgA glomerulonephritis	0.000254	0.000938	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR2—IgA glomerulonephritis	0.00025	0.000927	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGL—IgA glomerulonephritis	0.000243	0.000897	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—KYNU—IgA glomerulonephritis	0.000243	0.000897	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ATP5F1—IgA glomerulonephritis	0.000243	0.000897	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CHUK—IgA glomerulonephritis	0.000239	0.000885	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MAT2A—IgA glomerulonephritis	0.000228	0.000844	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CHST2—IgA glomerulonephritis	0.000228	0.000844	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ELOVL6—IgA glomerulonephritis	0.000216	0.0008	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—IMPA1—IgA glomerulonephritis	0.000216	0.0008	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DEGS1—IgA glomerulonephritis	0.000216	0.0008	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAP3K7—IgA glomerulonephritis	0.000212	0.000785	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—H2AFZ—IgA glomerulonephritis	0.000211	0.000781	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADAM10—IgA glomerulonephritis	0.00021	0.000776	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—IgA glomerulonephritis	0.000209	0.000773	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RHOA—IgA glomerulonephritis	0.000207	0.000766	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MARCKS—IgA glomerulonephritis	0.000198	0.000732	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GLIPR1—IgA glomerulonephritis	0.000198	0.000732	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UGCG—IgA glomerulonephritis	0.000198	0.000732	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GGCT—IgA glomerulonephritis	0.000198	0.000732	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VAV3—IgA glomerulonephritis	0.000197	0.000729	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RHOA—IgA glomerulonephritis	0.000188	0.000696	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GBE1—IgA glomerulonephritis	0.000184	0.00068	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTRR—IgA glomerulonephritis	0.000184	0.00068	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PDHX—IgA glomerulonephritis	0.000184	0.00068	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGPS—IgA glomerulonephritis	0.000184	0.00068	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—IgA glomerulonephritis	0.000183	0.000678	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HEXB—IgA glomerulonephritis	0.000178	0.000659	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PSAP—IgA glomerulonephritis	0.000178	0.000659	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SAT1—IgA glomerulonephritis	0.000173	0.000639	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TNFRSF21—IgA glomerulonephritis	0.000173	0.000639	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTMR3—IgA glomerulonephritis	0.000168	0.000622	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—YWHAZ—IgA glomerulonephritis	0.000168	0.000621	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—IgA glomerulonephritis	0.000164	0.000608	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—IgA glomerulonephritis	0.000161	0.000597	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C3—IgA glomerulonephritis	0.000158	0.000583	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CCNC—IgA glomerulonephritis	0.000156	0.000578	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GNS—IgA glomerulonephritis	0.000156	0.000578	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—IQGAP1—IgA glomerulonephritis	0.00015	0.000554	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGT—IgA glomerulonephritis	0.00015	0.000554	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HPSE—IgA glomerulonephritis	0.000147	0.000544	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMMR—IgA glomerulonephritis	0.000139	0.000515	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UCP2—IgA glomerulonephritis	0.000139	0.000515	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACSL1—IgA glomerulonephritis	0.000135	0.000499	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD80—IgA glomerulonephritis	0.000133	0.000491	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NRAS—IgA glomerulonephritis	0.000132	0.00049	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SEC23A—IgA glomerulonephritis	0.000127	0.000471	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TBL1XR1—IgA glomerulonephritis	0.000127	0.000471	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALOX5AP—IgA glomerulonephritis	0.000124	0.000459	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—IgA glomerulonephritis	0.000123	0.000457	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—IgA glomerulonephritis	0.000123	0.000453	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAPK1—IgA glomerulonephritis	0.000121	0.000447	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CA—IgA glomerulonephritis	0.000115	0.000427	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SERPINE1—IgA glomerulonephritis	0.000115	0.000426	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RHOA—IgA glomerulonephritis	0.000111	0.000411	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—IgA glomerulonephritis	0.00011	0.000408	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CA—IgA glomerulonephritis	0.000105	0.000388	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GNG12—IgA glomerulonephritis	0.000102	0.000378	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—RRM2—IgA glomerulonephritis	0.000102	0.000378	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NAMPT—IgA glomerulonephritis	9.47e-05	0.00035	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—IgA glomerulonephritis	8.82e-05	0.000326	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTEN—IgA glomerulonephritis	8.77e-05	0.000325	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PSME3—IgA glomerulonephritis	8.48e-05	0.000314	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—IgA glomerulonephritis	8.47e-05	0.000313	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NRAS—IgA glomerulonephritis	7.83e-05	0.00029	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CD44—IgA glomerulonephritis	7.63e-05	0.000282	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCA1—IgA glomerulonephritis	7.32e-05	0.000271	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—IgA glomerulonephritis	7.27e-05	0.000269	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK1—IgA glomerulonephritis	7.13e-05	0.000264	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—IgA glomerulonephritis	6.46e-05	0.000239	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMOX1—IgA glomerulonephritis	6.28e-05	0.000232	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CA—IgA glomerulonephritis	6.19e-05	0.000229	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TYMS—IgA glomerulonephritis	5.92e-05	0.000219	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CD36—IgA glomerulonephritis	5.46e-05	0.000202	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGT—IgA glomerulonephritis	4.91e-05	0.000182	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—IgA glomerulonephritis	4.56e-05	0.000169	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—IgA glomerulonephritis	3.77e-05	0.000139	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTEN—IgA glomerulonephritis	2.88e-05	0.000106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CA—IgA glomerulonephritis	2.03e-05	7.51e-05	CbGpPWpGaD
